BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7042789)

  • 1. Acute respiratory failure due to 2'Deoxycoformycin.
    Kahn RC; Carlon GC; Miller L; Howland WS; Tan C
    Intensive Care Med; 1982 Mar; 8(2):101-4. PubMed ID: 7042789
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.
    Dillman RO; Yu AL; Qiao CN
    West J Med; 1988 Mar; 148(3):334-7. PubMed ID: 3259051
    [No Abstract]   [Full Text] [Related]  

  • 3. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
    Camisa C; Grever MR; Bouroncle B
    J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation of actinic keratosis caused by systemic chemotherapy--2'-deoxycoformycin.
    Camisa C
    J Am Acad Dermatol; 1988 Oct; 19(4):758. PubMed ID: 3263402
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypersensitivity reactions to deoxycoformycin.
    O'Dwyer PJ; King SA; Eisenhauer E; Grem JL; Hoth DF
    Cancer Chemother Pharmacol; 1989; 23(3):173-5. PubMed ID: 2784360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraglomerular thrombosis with deoxycoformycin--reversible acute renal failure.
    Harris DC; Lawrence S; Bradstock KF; Carter JJ; Jones WG
    Clin Nephrol; 1984 Mar; 21(3):194-6. PubMed ID: 6608428
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenotypic conversion of acute leukaemia from T-lymphoblastic to myeloblastic induced by therapy with 2'-deoxycoformycin.
    Murphy SB; Stass S; Kalwinsky D; Rivera G
    Br J Haematol; 1983 Oct; 55(2):285-93. PubMed ID: 6604543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxycoformycin in the treatment of leukemias and lymphomas.
    Smyth JF; Prentice HG; Proctor S; Hoffbrand AV
    Ann N Y Acad Sci; 1985; 451():123-8. PubMed ID: 3878113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to deoxycoformycin in mature T cell malignancies.
    Ho AD; Stryckmans P; Zittoun R
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1483-4. PubMed ID: 3500754
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the choice of treatment for hairy cell leukemia?
    Golomb HM; Ratain MJ; Moormeier J
    J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
    Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
    Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity vasculitis associated with 2-deoxycoformycin and allopurinol therapy.
    Steinmetz JC; DeConti R; Ginsburg R
    Am J Med; 1989 Apr; 86(4):498-9. PubMed ID: 2784627
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of complete remission in T-cell acute lymphoblastic leukemia with deoxycoformycin (dcf) and 9-beta-D-arabinofuranosyladenine (ara-A).
    Yu AL; Mendelsohn J; Matsumoto SS
    Adv Exp Med Biol; 1986; 195 Pt A():491-6. PubMed ID: 3487920
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo effect of deoxycoformycin in human T cell leukemia.
    Yu AL; Kung FH; Bakay B; Nyhan WL
    Adv Exp Med Biol; 1979; 122B():373-9. PubMed ID: 397762
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia.
    Prentice HG; Russell NH; Lee N; Ganeshaguru K; Blacklock H; Piga A; Smyth JF; Hoffbrand AV
    Lancet; 1981 Dec; 2(8258):1250-4. PubMed ID: 6118669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism.
    Grem JL; King SA; Cheson BD; Leyland-Jones B; Wittes RE
    J Natl Cancer Inst; 1989 Mar; 81(6):448-53. PubMed ID: 2783980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
    Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
    Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.